However, it was readily possible to “construct” a 22.5% subgroup of patients (F2 diagnoses) and a 19.6% subgroup of patients (F3 diagnoses) for which highly significant correlations showed up between IgM levels on one hand, and the global schizophrenia and depression scores on the other. This evidence concerns the gene CD40LG and major depressive disorder.